disease interaction(s) of obesity with alcohol abuse
Jump to navigation
Jump to search
Management
- once-weekly semaglutide beneficial for patients with alcohol use disorder & obesity[1]
More general terms
References
- ↑ 1.0 1.1 Kruse Klausen M et al Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. Lancet. 2026 May 2;407(10540):1687-1698 PMID: https://pubmed.ncbi.nlm.nih.gov/42070571 Free article. Clinical Trial. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext